Tag Archives: New York Times

Ezetimibe no ha mostrado efectividad clinica en un ensayo clinico

Posted on January 14, 2008 by

Fuente: New York Times. MSD y Schering-Plough parece que van a perder mucho dinero vendiendo -enfermedad- ezetimibe. Al final va la version en castellano, gracias a Martin Cañas . By ALEX BERENSON A clinical trial of Zetia, a cholesterol-lowering drug … Continue reading →

Posted in Industria Farmaceutica, Medicalizacion, Medicamentos | Tagged , , , , , , , | 4 Comments

No hay almuerzo gratis II

Posted on November 29, 2007 by

NY Times MAGAZINE | November 25, 2007 Dr. Drug Rep By DANIEL CARLAT http://www.nytimes.com/2007/11/25/magazine/25memoir-t.html [Copied as fair use. Long posting] During a year of being paid to give talks to doctors about an antidepressant, a psychiatrist comes to terms with … Continue reading →

Posted in Incentivos, Industria Farmaceutica, Medicamentos | Tagged , , , , , , , , , , | 2 Comments

Sesgo de publicacion o sesgo de financiamiento? * Sign In to E-Mail or Save This * Print * Reprints * Share o Del.icio.us o Digg o Facebook o Newsvine o Permalink Article Tools Sponsored By By ERIC NAGOURNEY Published: November 13, 2007 Sesgo de publicacion o sesgo de financiamiento?

Posted on November 14, 2007 by

By ERIC NAGOURNEY Published: November 13, 2007 Inhalers are an effective treatment for asthma and other respiratory diseases, but they can have adverse side effects. The conclusions of studies on these effects apparently depend in part on who pays for … Continue reading →

Posted in Industria Farmaceutica, sesgo | Tagged , , , , , , , | Leave a comment

Sesgo de publicacion o sesgo de financiamiento? * Sign In to E-Mail or Save This * Print * Reprints * Share o Del.icio.us o Digg o Facebook o Newsvine o Permalink Article Tools Sponsored By By ERIC NAGOURNEY Published: November 13, 2007 Sesgo de publicacion o sesgo de financiamiento?

Posted on November 14, 2007 by

By ERIC NAGOURNEY Published: November 13, 2007 Inhalers are an effective treatment for asthma and other respiratory diseases, but they can have adverse side effects. The conclusions of studies on these effects apparently depend in part on who pays for … Continue reading →

Posted in Industria Farmaceutica, sesgo | Tagged , , , , , , | Leave a comment